Mitochondria are double-membrane organelles that generate most cellular ATP through oxidative phosphorylation while also regulating calcium homeostasis, redox balance, apoptosis, and innate immune signaling.[1][2] In the nervous system, they are especially critical because neurons have high energy demand, long axons, and strong dependence on compartment-specific ATP supply and calcium buffering.[1:1][3]
Mitochondria couple nutrient oxidation to ATP production through the electron transport chain and ATP synthase.[1:2] Neuronal firing, synaptic vesicle cycling, axonal transport, and ion-pump recovery all depend on this energy supply, which makes mitochondrial dysfunction disproportionately damaging in the brain.[2:1][3:1]
Healthy mitochondrial populations are maintained through fission, fusion, trafficking, and mitophagy. These quality-control processes determine whether damaged mitochondrial segments are repaired, redistributed, or removed.[2:2][4] Impairment of these systems can produce fragmented networks, bioenergetic failure, and increased oxidative stress.[2:3][4:1]
Mitochondria influence cell fate through reactive oxygen species signaling, calcium exchange with the endoplasmic reticulum, and regulation of intrinsic apoptosis.[1:3][2:4] In neurodegeneration, these roles intersect with neuroinflammation, oxidative stress pathway, and proteostasis failure.[2:5][3:2]
Mitochondrial dysfunction is a convergent feature of Alzheimer's disease, Parkinson's disease, amyotrophic lateral sclerosis, and Huntington's disease. Reported abnormalities include respiratory chain deficits, impaired mitochondrial transport, defective mitophagy, excess reactive oxygen species, and disturbed calcium handling.[2:6][3:3][4:2]
In Alzheimer's disease, mitochondrial stress interacts bidirectionally with amyloid-beta and tau pathology.[3:4] In Parkinson's disease, mitochondrial quality-control pathways involving PINK1, Parkin, and related trafficking/dynamics proteins are especially prominent.[3:5][4:3]
Many neuroprotective strategies indirectly or directly target mitochondria, including creatine supplementation for neurodegeneration, antioxidant therapy for neurodegeneration, mitophagy modulators, and mitochondrial dynamics interventions.[2:7][4:4] The main challenge is that mitochondria are essential across tissues, so CNS benefit must be balanced against systemic effects.
Klemmensen MM, Borrowman SH, Pearce C, Pyles B, Chandra B. Mitochondrial dysfunction in neurodegenerative disorders. Neurotherapeutics. 2024;21(1):e00292. ↩︎ ↩︎ ↩︎ ↩︎
Yang HM. Mitochondrial Dysfunction in Neurodegenerative Diseases. Cells. 2025;14(4):276. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Wang W, Zhao F, Ma X, Perry G, Zhu X. The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease. Journal of Alzheimer's Disease. 2020;75(3):705-720. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎ ↩︎
Giacomello M, Pyakurel A, Glytsou C, Scorrano L. Mitochondrial cristae shape determines respiratory chain supercomplexes assembly and respiratory efficiency. Cell Death and Differentiation. 2020;27(2):435-450. ↩︎ ↩︎ ↩︎ ↩︎ ↩︎